Reaction
Amniotic Cavity Infection reporting signals
As of the last recalculation, Amniotic Cavity Infection appears in 713 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is AMPICILLIN (PRR 149.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ampicillin | 40 | 149.3 | 150.0 |
| Ampicillin Sodium | 40 | 149.3 | 150.0 |
| Nevirapine | 13 | 42.8 | 42.9 |
| Zidovudine | 17 | 38.0 | 38.0 |
| Cefazolin | 10 | 32.4 | 32.5 |
| Magnesium Sulfate Heptahydrate | 13 | 29.7 | 29.7 |
| Magnesium Sulfate | 13 | 29.6 | 29.6 |
| Gentamicin | 13 | 29.5 | 29.6 |
| Magnesium Sulfate In Water For | 12 | 27.9 | 27.9 |
| Misoprostol | 9 | 27.3 | 27.3 |
| Cefazolin Sodium | 11 | 27.0 | 27.1 |
| Atazanavir | 13 | 26.9 | 26.9 |
| Gentamicin Sulfate | 13 | 24.4 | 24.5 |
| Raltegravir | 11 | 19.7 | 19.7 |
| Darunavir | 10 | 19.6 | 19.6 |
| Progesterone | 15 | 19.5 | 19.6 |
| Ritonavir | 18 | 18.4 | 18.4 |
| Ritonavir 100 Mg | 9 | 17.8 | 17.8 |
| Remdesivir | 7 | 15.5 | 15.5 |
| Emtricitabine And Tenofovir Alafenamide | 4 | 10.4 | 10.4 |
| Eptinezumab-Jjmr | 3 | 9.7 | 9.7 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 14 | 9.1 | 9.1 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 3 | 7.0 | 7.0 |
| Copper | 3 | 2.0 | 2.0 |